| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 759 | 752 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 759 | 752 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 1.150 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -391 | 752 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -414 | 729 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Hochlandmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 17.318 | 17.141 | - | 16.542 | 16.221 | 15.914 | 15.561 | 15.609 | 15.562 | 15.475 |
| Current Assets | 624 | 1.369 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventories | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 752 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 623 | 617 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | 3.079 | 3.777 | - | 3.645 | 3.574 | 3.506 | 3.428 | 3.439 | 3.429 | 3.410 |
| Social Capital | 124 | 122 | - | 118 | 116 | 114 | 111 | 112 | 111 | 111 |
| Debts | 14.862 | 14.733 | - | 12.897 | 12.648 | 12.408 | 12.132 | 12.170 | 12.133 | 12.065 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "142 - 142" | |||||||||
| CAEN Financial Year |
142
|
|||||||||
Comments - Hochlandmed Srl